Evidence map›Paper›PMID 20590496›Full record

Trial reportJournal of the American Veterinary Medical Association2010

Use of an activity monitor to detect response to treatment in dogs with osteoarthritis.

Dorothy Cimino Brown, Raymond C Boston, John T Farrar

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Veterinary Medical Association, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. A Review of the Monitoring Techniques Used to Detect Oestrus in Sows.Animals : an open access journal from MDPI · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dorothy Cimino BrownDepartment of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. dottie@vet.upenn.edu
Raymond C Boston
John T Farrar
University of Pennsylvania · US

Funding

Measure Validation and RCT- Dog Bone Cancer Pain ModelK08DA017720 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BROWN, DOROTHY C · 2004 to 2008
$756k
NIDA NIH HHS 1-K08-DA-017720-02NIDA NIH HHS K08 DA017720
6 · The paper itself

Abstract

objectiveTo determine whether an activity monitor (AM) could be used to detect changes in activity in dogs with osteoarthritis treated with carprofen or a placebo.

designRandomized controlled trial. ANIMALS: 70 dogs with no clinically important abnormalities other than osteoarthritis for which they were not currently being treated. PROCEDURES: Dogs wore an AM continuously for 21 days. On days 8 through 21, the dogs were treated with carprofen (n = 35) or a placebo (35). Total activity counts for days 1 through 7 (baseline) were compared with total activity counts for days 15 through 21 (endpoint). The change in total activity count from baseline to endpoint was assessed within each treatment group as well as between groups. Linear regression analysis was performed to test for an association between treatment and percentage change in activity counts while controlling for other variables.

resultsFor placebo-treated dogs, median baseline total activity count was not significantly different from median endpoint total activity count (1,378,408 vs 1,310,112, respectively). For dogs receiving carprofen, there was a significant increase in median activity count from baseline to endpoint (1,276,427 vs 1,374,133). When age and baseline activity counts were controlled for, dogs in the carpofen-treated group had a 20% increase in activity counts, compared with placebo-treated dogs (95% confidence interval, 10% to 26%). CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that the AM used in the present study may be a valid outcome assessment tool for documenting improved activity associated with treatment in dogs with osteoarthritis.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalCarbazolesDog DiseasesDogsFemaleMaleMonitoring, AmbulatoryMotor ActivityOsteoarthritisPain MeasurementAnti-Inflammatory Agents, Non-SteroidalCarbazolescarprofen

Identifiers

PMID20590496
PMCPMC2905214
OpenAlexW2149207178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.